In Other News

• AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

• FDA-Cleared Gastrointestinal Panel Detects 24 Pathogen Targets

• Fluid Biomarker Improves Diagnosis and Monitoring of Primary CNS Lymphoma

• Gene Fusion Patterns May Flag High Risk Solitary Fibrous Tumors

• Lysosomal Gene Defect Linked to Severe Childhood Brain Disorders

• Natera to Present Data on MRD-Guided Cancer Care at ASCO 2026

• Fujifilm Integrates Structured Reporting into Digital Pathology Workflow

• Tumor Genome Marker May Predict Treatment Benefit in Pediatric Cancers

• Fujifilm Integrates Structured Reporting into Digital Pathology Workflow

• New RNA Origami Method Supports Faster Targeted Testing for Repeat Expansion Disorders

• Genetic Testing Identifies Greater Inherited Sudden Cardiac Arrest Risk in Younger Individuals

• New CA19-9 Cutoff Value Helps Identify High-Risk Pancreatic Cancer Patients

• New AMR Assay Supports Rapid Infection Control Screening in Hospitals

• Immune Enzyme Linked to Treatment-Resistant Inflammatory Bowel Disease

• Higher Ferritin Threshold May Improve Iron Deficiency Detection in Children

• Blood-Based Biomarkers Show Promise for Psychosis Risk Prediction

• Immune Enzyme Linked to Treatment-Resistant Inflammatory Bowel Disease

• Diagnostic Gaps Complicate Bundibugyo Ebola Outbreak Response in Congo

• FDA Approves Expanded Liquid Biopsy Panel for Advanced Cancer Profiling

• AI-Enabled Assistant Unifies Molecular Workflow Planning and Support

• Strategic Collaboration Advances RNA Foundation Models for Precision Oncology

• Microbial Saliva Test Could Help Triage Esophageal Cancer Risk

• Hidden 'Jumping Gene' Variant Linked to Higher Pancreatic Cancer Risk